Medical Maneuvers
05/06/2014 | | Economic forecasting, Eisenberg and housing economics, Eisenberg and public speaking, Elliot eisenberg, Graphsandlaughs, MLS, Multiple listing service, Public speaking economist, econ70, economist on TV, economist on radio, eisenberg and economics, funniest economist, funny housing economist, graphsandlaughs and eisenberg, housing sales, mortgage banking, politics and economics
Pfizer’s $106.4 billion buyout offer of British pharmaceutical giant AstraZeneca is being largely driven by high US corporate taxes. At yearend 2013, Pfizer had $70 billion of overseas earnings that, if repatriated, would result in huge US taxes. Buying AstraZeneca with the overseas earnings eliminates the tax bill on the $70 billion and moving the merged firm’s headquarters from here to the lightly taxed UK reduces taxes on future earnings.